Wet AMD

BEDFORD, Mass., April 13, 2026 Ocular Therapeutix, Inc. has reported positive Week 52 data from its Phase 3 SOL-1...

TARRYTOWN, N.Y., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

INCHEON, South Korea, Oct. 9, 2025 — Celltrion, Inc., a global biopharmaceutical innovator, announced that the U.S. Food and...